Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 13

Zeitschriftenartikel

Niederwieser, Dietger ORCID logoORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID logoORCID: https://orcid.org/0000-0003-1478-5390 (2023): Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study. In: Annals of Hematology, Bd. 102: S. 547-561 [PDF, 3MB]

Bornhäuser, Martin; Schliemann, Christoph; Schetelig, Johannes; Röllig, Christoph; Kramer, Michael; Glass, Bertram; Platzbecker, Uwe; Burchert, Andreas; Hänel, Mathias; Müller, Lutz P.; Klein, Stefan; Bug, Gesine; Beelen, Dietrich; Rösler, Wolf; Schäfer-Eckart, Kerstin; Schmid, Christoph; Jost, Edgar; Lenz, Georg; Tischer, Johanna; Spiekermann, Karsten ORCID logoORCID: https://orcid.org/0000-0002-5139-4957; Pfirrmann, Markus ORCID logoORCID: https://orcid.org/0000-0002-8948-0690; Serve, Hubert; Stölzel, Friedrich; Alakel, Nael; Middeke, Jan Moritz; Thiede, Christian; Ehninger, Gerhard; Berdel, Wolfgang E. und Stelljes, Matthias (2023): Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia. In: JAMA Oncology, Bd. 9, Nr. 4: S. 519-526

Berdel, Andrew F.; Koch, Raphael; Gerss, Joachim; Hentrich, Marcus; Peceny, Rudolf; Bartscht, Tobias; Steffen, Bjoern; Bischoff, Marina; Spiekermann, Karsten; Angenendt, Linus; Mikesch, Jan-Henrik; Kewitz, Tobias; Butterfass-Bahloul, Trude; Serve, Hubert; Lenz, Georg; Berdel, Wolfgang E.; Krug, Utz und Schliemann, Christoph (2022): A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy. In: Annals of Hematology, Bd. 102, Nr. 1: S. 63-72

Middeke, Jan M.; Metzeler, Klaus H.; Roellig, Christoph; Kraemer, Michael; Eckardt, Jan-Niklas; Stasik, Sebastian; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Bruemmendorf, Tim H.; Naumann, Ralph; Steffen, Bjoern; Einsele, Hermann; Schaich, Markus; Burchert, Andreas; Neubauer, Andreas; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Schliemann, Christoph; Krause, Stefan W.; Haenel, Mathias; Frickhofen, Norbert; Noppeney, Richard; Kaiser, Ulrich; Kaufmann, Martin; Kunadt, Desiree; Woermann, Bernhard; Sockel, Katja; Bonin, Malte von; Herold, Tobias; Mueller-Tidow, Carsten; Platzbecker, Uwe; Berdel, Wolfgang E.; Serve, Hubert; Baldus, Claudia D.; Ehninger, Gerhard; Schetelig, Johannes; Hiddemann, Wolfgang; Bornhaeuser, Martin; Stoelzel, Friedrich und Thiede, Christian (2022): Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study. In: Blood Advances, Bd. 6, Nr. 5: S. 1394-1405

Kunadt, Desiree; Stasik, Sebastian; Metzeler, Klaus H.; Roellig, Christoph; Schliemann, Christoph; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Scholl, Sebastian; Hilgendorf, Inken; Bruemmendorf, Tim H.; Jost, Edgar; Steffen, Bjoern; Bug, Gesine; Einsele, Hermann; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Krause, Stefan W.; Haenel, Mathias; Hanoun, Maher; Kaufmann, Martin; Woermann, Bernhard; Kramer, Michael; Sockel, Katja; Egger-Heidrich, Katharina; Herold, Tobias; Ehninger, Gerhard; Burchert, Andreas; Platzbecker, Uwe; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Hiddemann, Wolfgang; Serve, Hubert; Stelljes, Matthias; Baldus, Claudia D.; Neubauer, Andreas; Schetelig, Johannes; Thiede, Christian; Bornhaeuser, Martin; Middeke, Jan M. und Stoelzel, Friedrich (2022): Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 126

Gerwing, Mirjam; Krähling, Tobias; Schliemann, Christoph; Harrach, Saliha; Schwöppe, Christian; Berdel, Andrew F.; Klein, Sebastian; Hartmann, Wolfgang; Wardelmann, Eva; Heindel, Walter L.; Lenz, Georg; Berdel, Wolfgang E. und Wildgruber, Moritz (2021): Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease. In: Cancers, Bd. 13, Nr. 23, 5880

Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz (2021): Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia. In: Blood Cancer Journal, Bd. 11, Nr. 10, 164

Floeth, Matthias; Elges, Sandra; Gerss, Joachim; Schwoeppe, Christian; Kessler, Torsten; Herold, Tobias; Wardelmann, Eva; Berdel, Wolfgang E.; Lenz, Georg; Mikesch, Jan-Henrik; Hartmann, Wolfgang; Schliemann, Christoph und Angenendt, Linus (2020): Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia. In: British Journal of Haematology, Bd. 192, Nr. 3: S. 494-503

Schliemann, Christoph; Gerwing, Mirjam; Heinzow, Hauke; Harrach, Saliha; Schwoeppe, Christian; Wildgruber, Moritz; Hansmeier, Anna A.; Angenendt, Linus; Berdel, Andrew F.; Stalmann, Ursula; Berning, Björna; Kratz-Albers, Karsten; Middelberg-Bisping, Kristina; Wiebe, Stefanie; Albring, Joern; Wilms, Christian; Hartmann, Wolfgang; Wardelmann, Eva; Kraehling, Tobias; Heindel, Walter; Gerss, Joachim; Bormann, Eike; Schmidt, Hartmut; Lenz, Georg; Kessler, Torsten; Mesters, Rolf M. und Berdel, Wolfgang E. (2020): First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study. In: Cancers, Bd. 12, Nr. 6, 1488

Angenendt, Linus; Bormann, Eike; Pabst, Caroline; Alla, Vijay; Goerlich, Dennis; Braun, Leonie; Dohlich, Kim; Schwoeppe, Christian; Bohlander, Stefan K.; Arteaga, Maria Francisca; Wethmar, Klaus; Hartmann, Wolfgang; Angenendt, Adrian; Kessler, Torsten; Mesters, Rolf M.; Stelljes, Matthias; Rothenberg-Thurley, Maja; Spiekermann, Karsten; Hebert, Josee; Sauvageau, Guy; Valk, Peter J. M.; Loewenberg, Bob; Serve, Hubert; Müller-Tidow, Carsten; Lenz, Georg; Woermann, Bernhard J.; Sauerland, M. Christina; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Krug, Utz; Metzeler, Klaus H.; Mikesch, Jan-Henrik; Herold, Tobias und Schliemann, Christoph (2019): The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia. In: Leukemia, Bd. 33, Nr. 12: S. 2830-2841

Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; Knecht, Kirsten M.; Buzovetsky, Olga; Kaderali, Lars; Schliemann, Christoph; Bohnenberger, Hanibal; Angenendt, Linus; Hartmann, Wolfgang; Wardelmann, Eva; Rothenburger, Tamara; Mohr, Sebastian; Scheich, Sebastian; Comoglio, Federico; Wilke, Anne; Stroebel, Philipp; Serve, Hubert; Michaelis, Martin; Ferreiros, Nerea; Geisslinger, Gerd; Xiong, Yong; Keppler, Oliver T. und Cinatl, Jindrich (2019): Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications, Bd. 10, 3475 [PDF, 2MB]

Lengfelder, Eva; Goerlich, Dennis; Nowak, Daniel; Spiekermann, Karsten; Haferlach, Claudia; Krug, Utz; Kreuzer, Karl-Anton; Braess, Jan; Schliemann, Christoph; Lindemann, Hans-Walter; Horst, Heinz A.; Schiel, Xaver; Flasshove, Michael; Hecht, Anna; Schnittger, Susanne; Schneider, Stephanie; Wörmann, Bernhard; Hofmann, Wolf-Karsten; Berdel, Wolfgang E.; Bormann, Eike; Sauerland, Cristina; Büchner, Thomas und Hiddemann, Wolfgang (2018): Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines. In: European Journal of Haematology, Bd. 100, Nr. 2: S. 154-162

Schneider, Constanze; Oellerich, Thomas; Baldauf, Hanna-Mari; Schwarz, Sarah-Marie; Thomas, Dominique; Flick, Robert; Bohnenberger, Hanibal; Kaderali, Lars; Stegmann, Lena; Cremer, Anjali; Martin, Margarethe; Lohmeyer, Julian; Michaelis, Martin; Hornung, Veit; Schliemann, Christoph; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wardelmann, Eva; Comoglio, Federico; Hansmann, Martin-Leo; Yakunin, Alexander F.; Geisslinger, Gerd; Stroebel, Philipp; Ferreiros, Nerea; Serve, Hubert; Keppler, Oliver T. und Cinatl, Jindrich (2017): SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. In: Nature Medicine, Bd. 23, Nr. 2: S. 250-255

Diese Liste wurde am Sat Apr 13 20:53:19 2024 CEST erstellt.